Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20921242 | 1.00 | CYP3A4 (0.38) | CYP3A4TDP1CALM1CES2CES1 | |
| SCHEMBL20921280 | 0.86 | ACHE (0.42) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL3649073 | 0.85 | CYP3A4 (0.32) | CYP3A4TDP1 | |
| SCHEMBL30828031 | 0.85 | TP53 (0.40) | CYP3A4TDP1CALM1CES2CES1 | |
| SCHEMBL3151329 | 0.85 | TDP1 (0.37) | CYP3A4TDP1CES2CES1ALDH1A1 | |
| SCHEMBL776216 | 0.85 | TP53 (0.40) | CYP3A4TDP1CALM1CES2CES1 | |
| SCHEMBL31561298 | 0.85 | HTR2A (0.37) | CYP3A4TDP1ALDH1A1 | |
| SCHEMBL29182302 | 0.85 | TP53 (0.40) | CYP3A4TDP1CALM1CES2CES1 | |
| SCHEMBL3329057 | 0.85 | CYP3A4 (0.32) | CYP3A4TDP1CES2CES1 | |
| SCHEMBL10473578 | 0.85 | IDO1 (0.35) | CYP3A4TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117342992-A | Process for preparing calcitol by using phytosterol and application thereof | 广东蔚莱生物科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-119735558-A | Preparation method and intermediate of aza-quinolinone derivative | 成都苑东生物制药股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20240309010-A1 | METHOD FOR PRODUCING BENZOXAZOLE DERIVATIVE HAVING BICYCLIC PIPERAZINE RING OR SALT THEREOF, AND METHOD FOR PRODUCING MATERIAL THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2024-09-19 | — | — | US | disclosed |
| EP-4365174-A1 | METHOD FOR PRODUCING BENZOXAZOLE DERIVATIVE HAVING BICYCLIC PIPERAZINE RING OR SALT THEREOF, AND METHOD FOR PRODUCING MATERIAL THEREOF | Meiji Seika Pharma Co., Ltd. (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117342992-A | Process for preparing calcitol by using phytosterol and application thereof | 广东蔚莱生物科技有限公司 | 2024-01-05 | — | — | CN | disclosed |
| EP-3643694-B1 | METHOD FOR PRODUCING BUTADIENE COMPOUND | DAIKIN IND LTD (JP) | 2023-11-15 | — | — | EP | disclosed |
| CN-110317535-B | Silicone-modified polyimide resin composition | 信越化学工业株式会社 | 2022-07-19 | — | — | CN | disclosed |
| CN-109843846-B | Synthesis of bicyclo [2.2.2] octane | 伊士曼化工公司 | 2022-07-05 | — | — | CN | disclosed |
| EP-3197905-B1 | METHOD FOR PRODUCING ETHYLENEDIALKYLPHOSPHINIC ACIDS, ESTERS AND SALTS, AND THE USE THEREOF AS FLAME RETARDANTS | CLARIANT INT LTD (CH) | 2021-06-30 | — | — | EP | disclosed |
| EP-3529230-B1 | SYNTHESIS OF BICYCLO(2.2.2)OCTANES | EASTMAN CHEM CO (US) | 2020-09-30 | — | — | EP | disclosed |
| US-6727294-B2 | RADIATION TRANSPARENT MOLDING MATERIALS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2004-04-27 | — | — | US | disclosed |
| EP-0794218-B1 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENG PLASTICS CORP (JP) | 2003-10-15 | — | — | EP | disclosed |
| EP-0753540-B1 | Polycarbonate resin composition | MITSUBISHI ENG PLASTICS CORP (JP) | 2003-06-11 | — | — | EP | disclosed |
| US-6359028-B1 | USED IN MEDICAL EQUIPMENT, DISCOLORATION INHIBITION | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2002-03-19 | — | — | US | disclosed |
| US-20010034419-A1 | Radiation transparent molding materials | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2001-10-25 | — | — | US | disclosed |
| US-6040367-A | EXCELLENT RESISTANCE TO AN IONIZING RADIATION, IN WHICH HETEROCYCLIC COMPOUND CONTAINING OXYMETHYLENE UNITS | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2000-03-21 | — | — | US | disclosed |
| US-5977206-A | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-11-02 | — | — | US | disclosed |
| US-5948838-A | 0.01 TO 5 PARTS BY WEIGHT OF A COMPOUND CONTAINING OXYMETHYLENE UNIT | MITSUBISHI ENGINEERING-PLASTICS CORP. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0794218-A2 | Polycarbonate resin composition stabilized against radiation | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-09-10 | — | — | EP | disclosed |
| EP-0753540-A2 | Polycarbonate resin composition | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 1997-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240309010-A1 | METHOD FOR PRODUCING BENZOXAZOLE DERIVATIVE HAVING BICYCLIC PIPERAZINE RING OR SALT THEREOF, AND METHOD FOR PRODUCING MATERIAL THEREOF | BAZ2B, JAK2, BRIX1 | CYP3A4 809/4885TDP1 3556/4885CALM1 3361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.